iShares Genomics Immunology and Healthcare ETF Rating $21.16 -0.34 (-1.58%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$21.20 +0.04 (+0.19%) As of 06/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.64Holdings in IDNA have an aggregate rating of Moderate Buy based on 418 analyst ratings issued in the past year covering 39 companies (60.4% of the portfolio).IDNA Aggregate Price Target$21.16High Prediction$21.16Average Prediction$21.16Low Prediction$21.16Holdings in IDNA have an aggregate price target of $21.16 and a range of $21.16 to $21.16 covering 39 companies (60.4% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.46%EXELExelixis$41.59-0.5%4.3886 of 5 stars2.47$39.76 -4.4%19Positive News4.83%SWTXSpringWorks Therapeutics$46.78+0.0%1.5468 of 5 stars2.13$52.57 12.4%8Positive News4.28%INCYIncyte$67.75-2.1%4.4032 of 5 stars2.17$72.53 7.1%18Trending News4.09%BNTXBioNTech$106.57+1.6%2.8439 of 5 stars2.83$138.25 29.7%18Trending News4.00%RVMDRevolution Medicines$40.59-1.3%4.4149 of 5 stars3.00$67.08 65.3%12Positive News3.69%ACLXArcellx$66.00-0.8%2.7882 of 5 stars3.07$111.33 68.7%14Gap Down3.68%MRKMerck & Co., Inc.$81.68-0.2%4.9956 of 5 stars2.43$109.19 33.7%21Positive News3.15%REGNRegeneron Pharmaceuticals$529.24+1.4%4.8799 of 5 stars2.85$836.48 58.1%26Analyst Revision3.14%BCRXBioCryst Pharmaceuticals$10.37-0.3%4.3451 of 5 stars2.89$16.56 59.6%9Positive News3.10%TWSTTwist Bioscience$33.52-0.3%4.1072 of 5 stars2.70$50.40 50.4%10Positive NewsGap Down2.95%MRNAModerna$26.67-2.5%4.4549 of 5 stars2.04$46.61 74.8%23Trending NewsOptions VolumeGap Down1.85%JANXJanux Therapeutics$24.90-2.6%2.3814 of 5 stars3.09$95.25 282.5%11Gap Up1.70%NVAXNovavax$6.94-2.9%3.853 of 5 stars2.50$19.20 176.7%6Gap Down1.36%GERNGeron$1.51-3.2%3.1463 of 5 stars2.78$5.06 235.3%91.12%ABCLAbCellera Biologics$3.20+1.6%2.4523 of 5 stars2.75$8.33 160.4%4Gap DownHigh Trading Volume0.98%XNCRXencor$9.19-2.5%4.1188 of 5 stars2.75$28.00 204.7%8Positive NewsGap Up0.86%IOVAIovance Biotherapeutics$2.24-3.0%4.6382 of 5 stars2.50$13.30 493.8%12Trending NewsGap Down0.81%IBRXImmunityBio$3.07-3.8%2.5091 of 5 stars3.20$12.25 299.0%5Gap DownHigh Trading Volume0.75%IMNMImmunome$9.20-6.0%1.614 of 5 stars3.00$23.33 153.6%6Positive NewsGap Down0.72%VIRVir Biotechnology$5.222.9916 of 5 stars2.86$32.86 529.4%7Positive NewsGap Down0.71%KURAKura Oncology$6.44-3.3%4.3639 of 5 stars2.93$24.50 280.4%140.68%RCUSArcus Biosciences$9.25-1.1%2.2627 of 5 stars2.90$24.13 160.8%10Gap Down0.63%VERVVerve Therapeutics$6.16-2.5%2.4363 of 5 stars3.00$25.75 318.0%6Gap Down0.62%ORICORIC Pharmaceuticals$9.63-0.4%3.8408 of 5 stars3.00$19.17 99.0%8Positive News0.60%CELCCelcuity$12.11-3.6%1.9041 of 5 stars3.17$30.80 154.3%6Positive News0.57%RIGLRigel Pharmaceuticals$20.52-3.7%3.2669 of 5 stars2.40$36.40 77.4%5Positive NewsGap Down0.57%MREOMereo BioPharma Group$2.76-0.7%1.8549 of 5 stars3.17$7.67 177.8%60.56%DNAGinkgo Bioworks$8.94-3.8%0.6025 of 5 stars1.67$5.77 -35.5%3Gap Down0.48%ARCTArcturus Therapeutics$12.38-2.1%3.2106 of 5 stars3.11$53.50 332.1%9Positive NewsGap Down0.44%PACBPacific Biosciences of California$1.20+1.7%2.0505 of 5 stars2.50$2.13 77.6%8Positive News0.35%CRSPCRISPR Therapeutics$41.36+0.2%3.2904 of 5 stars2.50$71.75 73.5%18Gap Down0.32%ALLOAllogene Therapeutics$1.34-4.3%3.8668 of 5 stars2.90$8.44 530.2%10Positive NewsGap Down0.27%FDMT4D Molecular Therapeutics$4.39-2.4%2.5382 of 5 stars2.60$29.56 573.2%100.25%OABIOmniAb$1.78+4.1%3.1155 of 5 stars3.00$7.00 293.3%3Positive NewsGap Up0.22%CRGXCARGO Therapeutics$4.39-2.0%2.3716 of 5 stars1.86$15.00 241.7%7Positive News0.22%LGNDLigand Pharmaceuticals$112.50-1.7%4.3878 of 5 stars3.00$146.14 29.9%70.16%SGMOSangamo Therapeutics$0.49-2.4%2.1681 of 5 stars2.67$4.50 816.5%6Positive NewsGap Down0.14%BEAMBeam Therapeutics$17.06-2.2%3.2421 of 5 stars3.00$48.75 185.8%15Positive NewsGap Down0.09%NTLAIntellia Therapeutics$8.31-0.5%4.6551 of 5 stars2.67$34.95 320.6%21Gap Up This page (NYSEARCA:IDNA) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDNA Stock Free IDNA Stock Alerts